NASDAQ:MASS 908 Devices (MASS) Stock Price, News & Analysis $5.52 +0.09 (+1.56%) As of 09:34 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About 908 Devices Stock (NASDAQ:MASS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get 908 Devices alerts:Sign Up Key Stats Today's Range$5.50▼$5.5050-Day Range$3.63▼$5.7952-Week Range$1.81▼$6.72Volume534 shsAverage Volume994,532 shsMarket Capitalization$198.13 millionP/E RatioN/ADividend YieldN/APrice Target$5.33Consensus RatingModerate Buy Company Overview908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.Read More… 908 Devices Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks29th Percentile Overall ScoreMASS MarketRank™: 908 Devices scored higher than 29% of companies evaluated by MarketBeat, and ranked 442nd out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.3 / 5Analyst RatingModerate Buy Consensus Rating908 Devices has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst Coverage908 Devices has only been the subject of 1 research reports in the past 90 days.Read more about 908 Devices' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for 908 Devices are expected to grow in the coming year, from ($1.99) to ($1.28) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of 908 Devices is -3.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of 908 Devices is -3.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share Ratio908 Devices has a P/B Ratio of 1.06. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about 908 Devices' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted10.68% of the float of 908 Devices has been sold short.Short Interest Ratio / Days to Cover908 Devices has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in 908 Devices has recently decreased by 1.77%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend Yield908 Devices does not currently pay a dividend.Dividend Growth908 Devices does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted10.68% of the float of 908 Devices has been sold short.Short Interest Ratio / Days to Cover908 Devices has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in 908 Devices has recently decreased by 1.77%, indicating that investor sentiment is improving. News and Social Media2.2 / 5News Sentiment0.95 News Sentiment908 Devices has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for 908 Devices this week, compared to 2 articles on an average week.Search InterestOnly 3 people have searched for MASS on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership5.0 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, 908 Devices insiders have bought more of their company's stock than they have sold. Specifically, they have bought $42,900.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders27.70% of the stock of 908 Devices is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions88.06% of the stock of 908 Devices is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about 908 Devices' insider trading history. Receive MASS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 908 Devices and its competitors with MarketBeat's FREE daily newsletter. Email Address MASS Stock News Headlines908 Devices Inc. (NASDAQ:MASS) Director Mark Spoto Purchases 10,000 SharesMay 16, 2025 | insidertrades.com908 Devices (NASDAQ:MASS) Receives Sell (E+) Rating from Weiss RatingsMay 27 at 3:15 AM | americanbankingnews.comElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless production of electric vehicles and solar technology is driving demand for the precious metal to unprecedented levels. Silver—critical for EV batteries, solar panels, and advanced electronics—is now at the center of a supply crisis.May 28, 2025 | GoldenCrest Metals (Ad)908 Devices to Participate in the William Blair 45th Annual Growth Stock ConferenceMay 22, 2025 | finance.yahoo.comQ2 Earnings Estimate for 908 Devices Issued By William BlairMay 20, 2025 | americanbankingnews.comStifel Nicolaus Reaffirms Their Buy Rating on 908 Devices (MASS)May 16, 2025 | theglobeandmail.comAnalysts Offer Insights on Healthcare Companies: 908 Devices (MASS), UnitedHealth (UNH) and Roche Holding AG (OtherRHHVF)May 14, 2025 | theglobeandmail.com908 Devices Inc (MASS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Rising LossesMay 14, 2025 | finance.yahoo.comSee More Headlines MASS Stock Analysis - Frequently Asked Questions How have MASS shares performed this year? 908 Devices' stock was trading at $2.20 at the start of the year. Since then, MASS shares have increased by 147.3% and is now trading at $5.44. View the best growth stocks for 2025 here. How were 908 Devices' earnings last quarter? 908 Devices Inc. (NASDAQ:MASS) issued its earnings results on Tuesday, May, 13th. The company reported ($0.22) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.05. The business earned $11.78 million during the quarter, compared to analysts' expectations of $11.90 million. 908 Devices had a negative trailing twelve-month return on equity of 24.60% and a negative net margin of 109.11%. Read the conference call transcript. When did 908 Devices IPO? 908 Devices (MASS) raised $101 million in an initial public offering on Friday, December 18th 2020. The company issued 6,300,000 shares at $15.00-$17.00 per share. Cowen, SVB Leerink, Stifel and William Blair served as the underwriters for the IPO. Who are 908 Devices' major shareholders? 908 Devices' top institutional investors include AWM Investment Company Inc. (14.55%), ARK Investment Management LLC (8.11%), First Light Asset Management LLC (4.76%) and Invesco Ltd. (1.82%). Insiders that own company stock include Christopher D Brown, Kevin J Knopp, Joseph H Iv Griffith, Mark Spoto and Michael S Turner. View institutional ownership trends. How do I buy shares of 908 Devices? Shares of MASS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of 908 Devices own? Based on aggregate information from My MarketBeat watchlists, some other companies that 908 Devices investors own include Meta Platforms (META), Tesla (TSLA), NVIDIA (NVDA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Visa (V). Company Calendar Last Earnings5/13/2025Today5/28/2025Next Earnings (Estimated)8/05/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Measuring & controlling devices, not elsewhere classified Sub-IndustryMeasuring And Control Equipment Current SymbolNASDAQ:MASS CIK1555279 Webwww.908devices.com Phone857-254-1500FaxN/AEmployees60Year FoundedN/APrice Target and Rating Average Stock Price Target$5.33 High Stock Price Target$6.00 Low Stock Price Target$4.00 Potential Upside/Downside-2.0%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.54) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$36.40 million Net Margins-109.11% Pretax Margin-109.59% Return on Equity-24.60% Return on Assets-19.23% Debt Debt-to-Equity RatioN/A Current Ratio4.24 Quick Ratio3.54 Sales & Book Value Annual Sales$63.99 million Price / Sales3.05 Cash FlowN/A Price / Cash FlowN/A Book Value$5.11 per share Price / Book1.06Miscellaneous Outstanding Shares35,861,000Free Float25,177,000Market Cap$195.08 million OptionableOptionable Beta0.26 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (NASDAQ:MASS) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredDollar Collapse Warning: Protect Your Wealth NOWGlobal central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Ame...Lear Capital | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 908 Devices Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 908 Devices With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.